Premaitha expands prenatal product into two new markets
27th Jan 2016 16:32
(ShareCast News) - Premaitha Health was expanding its popular prenatal screening product's reach on Wednesday, announcing two new service contracts with customers in Armenia and the Republic of Moldova. The AIM-listed medical developer said the contracts would expand Premaitha's customer base into n
Read morePremaitha Health confident about full year after Thermo Fisher deal
14th Dec 2015 15:43
(ShareCast News) - Pre-natal testing company Premaitha Health reported a slightly larger loss as well as a larger provision for its looming legal case, but has signed up with a major US manufacturing partner. Premaitha, which has developed the IONA non-invasive pre-natal test for Down's and other ge
Read morePremaitha Health signs distribution deal for Greece
2nd Oct 2015 12:02
(ShareCast News) - Premaitha Health has signed a distribution agreement with Greece-based Antisel to provide its IONA test to clinical laboratories in the country. The AIM listed company made the announcement on Friday. The IONA test is the first CE-marked test for non-invasive prenatal testing (NI
Read morePremaitha Health's annual loss widens on exceptional costs
22nd Sep 2015 09:14
(ShareCast News) - Molecular diagnostic group Premaitha Health reported a wider annual pre-tax loss on the back of costs related to its reverse takeover. In the 13 months to the end of March, the group posted a pre-tax loss of £6.8m compared with a loss of £1.5m in the corresponding period in 2014.
Read morePremaitha to fund pre-natal test development with £8m share placing
2nd Jul 2015 10:07
Shares in Premaitha Health were perked up by a proposal by the company to raise £8m of funding for its non-invasive pre-natal test (NIPT) via a share placing. The company, which floated on AIM in July last year via a reverse takeover, will place 40m shares at 20p per share and divert the proceeds to
Read morePremaitha to provide This Is My clinics with IONA tests
22nd Jun 2015 11:40
Premaitha Health announced that it has signed a deal with This Is My Ltd, to supply its non-invasive IONA pre-natal test. Premaitha will provide the tests for the This Is My clinics, which offer ultrasound and pregnancy screenings, in Leeds, Manchester, Liverpool, Hull, Coventry, Halifax, Durham and
Read morePremaitha Health guides to full-year losses
19th Jun 2015 07:53
Shares in Premaitha Health dropped sharply on Friday after the prenatal diagnostics group said it would report an operating loss of £4.9m-5.3m for the year ended 31 March. The company, which is currently developing non-invasive prenatal tests (NIPT) such as its flagship product IONA, said that this
Read morePremaitha Health appoints new chief financial officer
4th Jun 2015 14:31
Shareholders in molecular diagnostics company Premaitha Health welcomed the immediate appointment of a new chief financial officer. Barry Hextall will replace Mark Collingbourne, who has decided to step down to focus on his other business interests and directorships. Hextall has more than 15 years'
Read morePremaitha Health files 'robust defence' in Illumina's patent infringement suit
5th May 2015 10:54
Premaitha Health has filed a "robust defence" in court regarding Illumina's patent infringement suit against the molecular diagnostics company. The suit was filed in the High Court of Justice, Chancery Division, Patents Court in the UK in March as Illumina argued that Premaitha's IONA test infringes
Read morePremaitha Health wins contract with NHS Trust
23rd Mar 2015 14:19
Shares in Premaitha Health jumped on Monday after announcing a three-year contract with St George's University Hospitals NHS Foundation Trust. Premiatha will provide its IONA test, a non-invasive prenatal test (NIPT), to the hospital, which will be the first NHS facility to offer an in-house NIPT sc
Read moreIllumina files patent infringement suit against Premaitha Health
16th Mar 2015 13:46
Shares in Premaitha Health fell sharply on Monday after Illumina and its subsidiary Verinata Health filed a patent infringement suit against the molecular diagnostics company on the same day that it inked a distribution agreement for one of its products. The suit was filed in the High Court of Justi
Read more